Paper22207756
Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.
Marcinkiewicz MM and 2 others. J Biol Chem, 2012. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa. Papers, record 22207756. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22207756
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Coagulation | Major topic |
| Disulfides | Major topic |
| Factor IX | Major topic |
| Factor XIa | Major topic |
| Binding, Competitive | |
| Catalytic Domain | |
| Enzyme Activation | |
| HEK293 Cells | |
| Humans | |
| Mutagenesis, Site-Directed | |
| Oxidation-Reduction | |
| Peptide Hydrolases | |
| Substrate Specificity |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 HL074124 | NHLBI NIH HHS | United States | P01HL074124 | PubMed and NIH | NIH RePORTER |
| R01 HL046213 | NHLBI NIH HHS | United States | R01HL046213 | PubMed and NIH | NIH RePORTER |
| HL46213 | NHLBI NIH HHS | United States | R01HL046213 | PubMed and NIH | NIH RePORTER |
| HL74124 | NHLBI NIH HHS | United States | P01HL074124 | PubMed and NIH | NIH RePORTER |
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16,085,935 | Structural and mutational analyses of the molecular interactions between the catalytic domain of factor XIa and the Kunitz protease inhibitor domain of protease nexin 2. | J Biol Chem | 2005 | https://conductscience.org/library/papers/16085935 | PubMed |
| 2 | 15,545,266 | Crystal structures of the FXIa catalytic domain in complex with ecotin mutants reveal substrate-like interactions. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15545266 | PubMed |
| 3 | 9,315,846 | Exosites determine macromolecular substrate recognition by prothrombinase. | Biochemistry | 1997 | https://conductscience.org/library/papers/9315846 | PubMed |
| 4 | 3,422,166 | The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. | Blood | 1988 | https://conductscience.org/library/papers/3422166 | PubMed |
| 5 | 3,875,611 | Functional characterization of human blood coagulation factor XIa using hybridoma antibodies. | J Biol Chem | 1985 | https://conductscience.org/library/papers/3875611 | PubMed |
| 6 | 16,699,514 | Crystal structure of the factor XI zymogen reveals a pathway for transactivation. | Nat Struct Mol Biol | 2006 | https://conductscience.org/library/papers/16699514 | PubMed |
| 7 | 17,676,929 | Macromolecular substrate-binding exosites on both the heavy and light chains of factor XIa mediate the formation of the Michaelis complex required for factor IX-activation. | Biochemistry | 2007 | https://conductscience.org/library/papers/17676929 | PubMed |
| 8 | 11,733,491 | Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11733491 | PubMed |
| 9 | 1,652,157 | Factor XI activation in a revised model of blood coagulation. | Science | 1991 | https://conductscience.org/library/papers/1652157 | PubMed |
| 10 | 1,931,959 | The coagulation cascade: initiation, maintenance, and regulation. | Biochemistry | 1991 | https://conductscience.org/library/papers/1931959 | PubMed |
| 11 | 17,884,987 | Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17884987 | PubMed |
| 12 | 3,636,155 | Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. | Biochemistry | 1986 | https://conductscience.org/library/papers/3636155 | PubMed |
| 13 | 15,829,482 | Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15829482 | PubMed |
| 14 | 271,951 | Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/271951 | PubMed |
| 15 | 659,613 | Activation of human factor IX (Christmas factor). | J Clin Invest | 1978 | https://conductscience.org/library/papers/659613 | PubMed |
| 16 | 6,604,546 | Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H- and 125I-labeled factor IX. | Biochemistry | 1983 | https://conductscience.org/library/papers/6604546 | PubMed |
| 17 | 6,604,052 | Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI. | J Biol Chem | 1983 | https://conductscience.org/library/papers/6604052 | PubMed |
| 18 | 10,593,931 | Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10593931 | PubMed |
| 19 | 2,019,570 | Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. | J Biol Chem | 1991 | https://conductscience.org/library/papers/2019570 | PubMed |
| 20 | 915,004 | Association of factor XI and high molecular weight kininogen in human plasma. | J Clin Invest | 1977 | https://conductscience.org/library/papers/915004 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 22,961,984 | A sequential mechanism for exosite-mediated factor IX activation by factor XIa. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22961984 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F11 | 2,160 | PubTator's text mining | https://conductscience.org/library/genes/2160 | NCBI Gene |
| F9 | 2,158 | PubTator's text mining | https://conductscience.org/library/genes/2158 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22207756
GET https://conductscience.org/api/papers/v1/22207756/references?page=2